FT 07/02/19 | Vox Markets

FT 07/02/19

Interserve (IRV) rescue deal runs into trouble. Largest shareholder Coltrane attempts to derail proposal and demands removal of board

Lex – Interserve (IRV): greatest woe on earth. Any business that gets most of its turnover from one customer puts itself at risk

GlaxoSmithKline (GSK) strategy revamp and shingles drug help lift earnings. UK drugmaker warns 2019 earnings likely to be hit by generic rival to Advair asthma drug

Ocado Group (OCDO) warns fire at key warehouse will hit sales growth. Shares fall sharply after damage at Andover site is found to be worse than expected

Interserve (IRV) unveils rescue plan that hands control to banks. Debt-for-equity swap would wipe out shareholders of struggling UK government contractor

Lender CYBG (CYBG) forecasts slimmer decline in margins than feared. Bank says it is off to ‘good start’ following £1.7bn purchase of Virgin Money

Help to Buy and low interest rates help Barratt Developments (BDEV) post strong first half. Homebuilder says favourable mortgage rates and stable land market ensured growth

twitter_share

Mentioned in this post

BDEV
Barratt Developments
CYBG
CYBG
GSK
GlaxoSmithKline
IRV
Interserve
OCDO
Ocado Group